Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Transition Readiness Not Associated With Measures of Health in Youth With IBD.

Arvanitis M, Hart LC, DeWalt DA, Díaz-González de Ferris ME, Sawicki GS, Long MD, Martin CF, Kappelman MD.

Inflamm Bowel Dis. 2020 Feb 28. pii: izaa026. doi: 10.1093/ibd/izaa026. [Epub ahead of print]

PMID:
32109284
2.

Ultrasound imaging links soleus muscle neuromechanics and energetics during human walking with elastic ankle exoskeletons.

Nuckols RW, Dick TJM, Beck ON, Sawicki GS.

Sci Rep. 2020 Feb 27;10(1):3604. doi: 10.1038/s41598-020-60360-4.

3.

The exoskeleton expansion: improving walking and running economy.

Sawicki GS, Beck ON, Kang I, Young AJ.

J Neuroeng Rehabil. 2020 Feb 19;17(1):25. doi: 10.1186/s12984-020-00663-9. Review.

4.

Correction to 'Humans falling in holes: adaptations in lower-limb joint mechanics in response to a rapid change in substrate height during human hopping'.

Dick TJ, Punith LK, Sawicki GS.

J R Soc Interface. 2020 Feb;17(163):20200047. doi: 10.1098/rsif.2020.0047. Epub 2020 Feb 19. No abstract available.

5.

Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis.

Suthoff E, Mainz JG, Cox DW, Thorat T, Grossoehme DH, Fridman M, Sawicki GS, Rosenfeld M.

J Pediatr. 2019 Dec;215:164-171.e2. doi: 10.1016/j.jpeds.2019.08.038.

PMID:
31761140
6.

Male gender and unemployment are associated with lower levels of perceived social support in adults with cystic fibrosis.

Flewelling KD, Sellers DE, Sawicki GS, Robinson WM, Dill EJ.

J Psychosom Res. 2019 Dec;127:109858. doi: 10.1016/j.jpsychores.2019.109858. Epub 2019 Nov 2.

PMID:
31706070
7.

Humans falling in holes: adaptations in lower-limb joint mechanics in response to a rapid change in substrate height during human hopping.

Dick TJM, Punith LK, Sawicki GS.

J R Soc Interface. 2019 Oct 31;16(159):20190292. doi: 10.1098/rsif.2019.0292. Epub 2019 Oct 2. Erratum in: J R Soc Interface. 2020 Feb;17(163):20200047.

PMID:
31575349
8.

Exoskeletons Improve Locomotion Economy by Reducing Active Muscle Volume.

Beck ON, Punith LK, Nuckols RW, Sawicki GS.

Exerc Sport Sci Rev. 2019 Oct;47(4):237-245. doi: 10.1249/JES.0000000000000204.

PMID:
31436749
9.

Hurry Up and Get Out of the Way! Exploring the Limits of Muscle-Based Latch Systems for Power Amplification.

Abbott EM, Nezwek T, Schmitt D, Sawicki GS.

Integr Comp Biol. 2019 Dec 1;59(6):1546-1558. doi: 10.1093/icb/icz141.

PMID:
31418784
10.

Predictors of pulmonary exacerbation treatment in cystic fibrosis.

Sanders DB, Ostrenga JS, Rosenfeld M, Fink AK, Schechter MS, Sawicki GS, Flume PA, Morgan WJ.

J Cyst Fibros. 2019 Jun 27. pii: S1569-1993(18)30763-X. doi: 10.1016/j.jcf.2019.06.008. [Epub ahead of print]

PMID:
31257102
11.

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.

Volkova N, Moy K, Evans J, Campbell D, Tian S, Simard C, Higgins M, Konstan MW, Sawicki GS, Elbert A, Charman SC, Marshall BC, Bilton D.

J Cyst Fibros. 2020 Jan;19(1):68-79. doi: 10.1016/j.jcf.2019.05.015. Epub 2019 Jun 10.

12.

Chronic rhino-sinusitis treatment in children with cystic fibrosis: A cross-sectional survey of pediatric pulmonologists and otolaryngologists.

Lowery AS, Gallant JN, Woodworth BA, Brown RF, Sawicki GS, Shannon CN, Virgin FW.

Int J Pediatr Otorhinolaryngol. 2019 Sep;124:139-142. doi: 10.1016/j.ijporl.2019.05.034. Epub 2019 Jun 1.

PMID:
31195306
13.

Trailing limb angle is a surrogate for propulsive limb forces during walking post-stroke.

Lewek MD, Sawicki GS.

Clin Biomech (Bristol, Avon). 2019 Jul;67:115-118. doi: 10.1016/j.clinbiomech.2019.05.011. Epub 2019 May 9.

PMID:
31102839
14.

Mechanics and energetics of post-stroke walking aided by a powered ankle exoskeleton with speed-adaptive myoelectric control.

McCain EM, Dick TJM, Giest TN, Nuckols RW, Lewek MD, Saul KR, Sawicki GS.

J Neuroeng Rehabil. 2019 May 15;16(1):57. doi: 10.1186/s12984-019-0523-y.

15.

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC; KLIMB study group.

J Cyst Fibros. 2019 Nov;18(6):838-843. doi: 10.1016/j.jcf.2019.03.009. Epub 2019 Apr 30.

16.

Development of a Novel Gait Analysis Tool Measuring Center of Pressure for Evaluation of Canine Chronic Thoracolumbar Spinal Cord Injury.

Lewis MJ, Williams KD, Langley T, Jarvis LM, Sawicki GS, Olby NJ.

J Neurotrauma. 2019 Nov 1;36(21):3018-3025. doi: 10.1089/neu.2019.6479. Epub 2019 Jun 6.

PMID:
31044646
17.

Linkage of the CF foundation patient registry with the pediatric health information system database.

Cogen JD, Hall M, Loeffler DR, Gove N, Onchiri F, Sawicki GS, Fink AK.

Pediatr Pulmonol. 2019 Jun;54(6):721-728. doi: 10.1002/ppul.24272. Epub 2019 Mar 18.

PMID:
30887732
18.

Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities.

Lanzkron S, Sawicki GS, Hassell KL, Konstan MW, Liem RI, McColley SA.

J Clin Transl Sci. 2018 Oct;2(5):334-342. doi: 10.1017/cts.2018.338. Review.

19.

Interprofessional provider educational needs and preferences regarding the provision of sexual and reproductive health care in cystic fibrosis.

Kazmerski TM, Nelson EB, Newman LR, Haviland MJ, Luff D, Leichtner AM, Hayes MM, Miller E, Emans SJ, Sawicki GS.

J Cyst Fibros. 2019 Sep;18(5):671-676. doi: 10.1016/j.jcf.2019.01.015. Epub 2019 Feb 19.

PMID:
30795973
20.

Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis.

Flewelling KD, Sellers DE, Sawicki GS, Robinson WM, Dill EJ.

J Cyst Fibros. 2019 Jul;18(4):572-576. doi: 10.1016/j.jcf.2019.01.013. Epub 2019 Feb 13.

PMID:
30772245
21.

Cystic Fibrosis And Ivacaftor Use: The Authors Reply.

Feng LB, Grosse SD, Sawicki GS.

Health Aff (Millwood). 2019 Feb;38(2):328. doi: 10.1377/hlthaff.2018.05268. No abstract available.

22.

Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.

McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS.

Lancet Respir Med. 2019 Apr;7(4):325-335. doi: 10.1016/S2213-2600(18)30460-0. Epub 2019 Jan 24.

PMID:
30686767
23.

Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016.

Grosse SD, Do TQN, Vu M, Feng LB, Berry JG, Sawicki GS.

Pediatr Pulmonol. 2018 Dec;53(12):1611-1618. doi: 10.1002/ppul.24178. Epub 2018 Oct 31.

24.

Developing Sexual and Reproductive Health Educational Resources for Young Women with Cystic Fibrosis: A Structured Approach to Stakeholder Engagement.

Kazmerski TM, Miller E, Sawicki GS, Thomas P, Prushinskaya O, Nelson E, Hill K, Miller A, Jean Emans S.

Patient. 2019 Apr;12(2):267-276. doi: 10.1007/s40271-018-0342-4.

PMID:
30361885
25.

Rate and predictors of prescription of lumacaftor - Ivacaftor in the 18 months following approval in the United States.

Sawicki GS, Fink AK, Schechter MS, Loeffler DR, Mayer-Hamblett N.

J Cyst Fibros. 2018 Nov;17(6):742-746. doi: 10.1016/j.jcf.2018.08.007. Epub 2018 Sep 7.

PMID:
30201329
26.

Sexual and Reproductive Health of Young Women With Cystic Fibrosis: A Concept Mapping Study.

Kazmerski TM, Prushinskaya OV, Hill K, Nelson E, Leonard J, Mogren K, Pitts SAB, Roboff J, Uluer A, Emans SJ, Miller E, Sawicki GS.

Acad Pediatr. 2019 Apr;19(3):307-314. doi: 10.1016/j.acap.2018.08.011. Epub 2018 Aug 31.

PMID:
30176294
27.

The burden of cystic fibrosis in the Medicaid population.

Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS.

Clinicoecon Outcomes Res. 2018 Jul 25;10:423-431. doi: 10.2147/CEOR.S162021. eCollection 2018.

28.

Overcoming psychosocial challenges in cystic fibrosis: Promoting resilience.

Muther EF, Polineni D, Sawicki GS.

Pediatr Pulmonol. 2018 Nov;53(S3):S86-S92. doi: 10.1002/ppul.24127. Epub 2018 Jul 6. Review.

PMID:
29979497
29.

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor.

Bessonova L, Volkova N, Higgins M, Bengtsson L, Tian S, Simard C, Konstan MW, Sawicki GS, Sewall A, Nyangoma S, Elbert A, Marshall BC, Bilton D.

Thorax. 2018 Aug;73(8):731-740. doi: 10.1136/thoraxjnl-2017-210394. Epub 2018 May 10.

30.

Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study.

Rho J, Ahn C, Gao A, Sawicki GS, Keller A, Jain R.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1055-1063. doi: 10.1164/rccm.201711-2357OC.

31.

Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

Feng LB, Grosse SD, Green RF, Fink AK, Sawicki GS.

Health Aff (Millwood). 2018 May;37(5):773-779. doi: 10.1377/hlthaff.2017.1554.

32.

Perspectives of adolescent girls with cystic fibrosis and parents on disease-specific sexual and reproductive health education.

Kazmerski TM, Hill K, Prushinskaya O, Nelson E, Greenberg J, Pitts SA, Borrero S, Miller E, Sawicki GS.

Pediatr Pulmonol. 2018 Aug;53(8):1027-1034. doi: 10.1002/ppul.24015. Epub 2018 Apr 26.

PMID:
29696829
33.

Cystic fibrosis patient registries: A valuable source for clinical research.

Dasenbrook EC, Sawicki GS.

J Cyst Fibros. 2018 Jul;17(4):433-440. doi: 10.1016/j.jcf.2018.03.001. Epub 2018 Mar 16. Review.

PMID:
29555479
34.

Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.

Kirkham HS, Staskon F, Hira N, McLane D, Kilgore KM, Parente A, Kim S, Sawicki GS.

Pediatr Pulmonol. 2018 Jun;53(6):720-727. doi: 10.1002/ppul.23978. Epub 2018 Mar 7.

35.

Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.

Konstan MW, VanDevanter DR, Sawicki GS, Pasta DJ, Foreman AJ, Neiman EA, Morgan WJ.

Ann Am Thorac Soc. 2018 Apr;15(4):485-493. doi: 10.1513/AnnalsATS.201706-486OC.

PMID:
29313709
36.

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.

Sawicki GS, Ostrenga J, Petren K, Fink AK, D'Agostino E, Strassle C, Schechter MS, Rosenfeld M.

Ann Am Thorac Soc. 2018 Feb;15(2):234-240. doi: 10.1513/AnnalsATS.201705-357OC.

PMID:
29220199
37.

Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis.

Barsky EE, Pereira LM, Sullivan KJ, Wong A, McAdam AJ, Sawicki GS, Priebe GP, Goobie SM.

J Cyst Fibros. 2018 May;17(3):e25-e31. doi: 10.1016/j.jcf.2017.10.010. Epub 2017 Nov 2.

PMID:
29103924
38.

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, Konstan MW, Morgan WJ, Pasta DJ, Moss RB.

J Cyst Fibros. 2018 Jul;17(4):503-510. doi: 10.1016/j.jcf.2017.10.003. Epub 2017 Oct 31.

39.

Quantifying center of pressure variability in chondrodystrophoid dogs.

Blau SR, Davis LM, Gorney AM, Dohse CS, Williams KD, Lim JH, Pfitzner WG, Laber E, Sawicki GS, Olby NJ.

Vet J. 2017 Aug;226:26-31. doi: 10.1016/j.tvjl.2017.07.001. Epub 2017 Jul 20.

40.

Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis.

Kazmerski TM, Sawicki GS, Miller E, Jones KA, Abebe KZ, Tuchman LK, Ladores S, Rubenstein RC, Sagel SD, Weiner DJ, Pilewski JM, Orenstein DM, Borrero S.

J Cyst Fibros. 2018 Jan;17(1):64-70. doi: 10.1016/j.jcf.2017.08.009. Epub 2017 Sep 1.

PMID:
28866451
41.

Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.

Barsky EE, Williams KA, Priebe GP, Sawicki GS.

Pediatr Pulmonol. 2017 Oct;52(10):1276-1282. doi: 10.1002/ppul.23781. Epub 2017 Aug 16.

PMID:
28815999
42.

Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies.

Dellon E, Goldfarb SB, Hayes D Jr, Sawicki GS, Wolfe J, Boyer D.

Pediatr Pulmonol. 2017 Nov;52(S48):S61-S68. doi: 10.1002/ppul.23748. Epub 2017 Aug 8. Review.

PMID:
28786560
43.

Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis.

Kazmerski TM, Sawicki GS, Miller E, Jones KA, Abebe KZ, Tuchman LK, Ladores S, Rubenstein RC, Sagel SD, Weiner DJ, Pilewski JM, Orenstein DM, Borrero S.

J Cyst Fibros. 2018 Jan;17(1):57-63. doi: 10.1016/j.jcf.2017.07.017. Epub 2017 Aug 1.

PMID:
28774749
44.

Preparation for Transition to Adult Care Among Medicaid-Insured Adolescents.

Sawicki GS, Garvey KC, Toomey SL, Williams KA, Hargraves JL, James T, Raphael JL, Giardino AP, Schuster MA, Finkelstein JA.

Pediatrics. 2017 Jul;140(1). pii: e20162768. doi: 10.1542/peds.2016-2768.

45.

Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function Decline.

Sawicki GS, McKone EF, Millar SJ, Pasta DJ, Konstan MW, Lubarsky B, Wagener JS.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1673-1676. doi: 10.1164/rccm.201608-1678LE. No abstract available.

PMID:
28617084
46.

Impact of an Individual Mandate and Other Health Reforms on Dependent Coverage for Adolescents and Young Adults.

Wisk LE, Finkelstein JA, Toomey SL, Sawicki GS, Schuster MA, Galbraith AA.

Health Serv Res. 2018 Jun;53(3):1581-1599. doi: 10.1111/1475-6773.12723. Epub 2017 May 30.

47.

Utilization of a patient-centered asthma passport tool in a subspecialty clinic.

Greenberg J, Prushinskaya O, Harris JD, Guidetti-Myers G, Steiding J, Sawicki GS, Gaffin JM.

J Asthma. 2018 Feb;55(2):180-187. doi: 10.1080/02770903.2017.1323916. Epub 2017 May 26.

48.

Early Lung Function Decline in Cystic Fibrosis. Can Registry Data Explain Divergent Phenotypes?

Kazmerski TM, Sawicki GS.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):407-409. doi: 10.1164/rccm.201704-0813ED. No abstract available.

PMID:
28504907
49.

Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients.

Sobin L, Kawai K, Irace AL, Gergin O, Cunningham M, Sawicki GS, Adil EA.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):302-308. doi: 10.1177/0194599817702332. Epub 2017 Apr 25.

PMID:
28440108
50.

A benchtop biorobotic platform for in vitro observation of muscle-tendon dynamics with parallel mechanical assistance from an elastic exoskeleton.

Robertson BD, Vadakkeveedu S, Sawicki GS.

J Biomech. 2017 May 24;57:8-17. doi: 10.1016/j.jbiomech.2017.03.009. Epub 2017 Mar 21.

PMID:
28431748

Supplemental Content

Loading ...
Support Center